Cannabinoid and lipid-mediated vasorelaxation in retinal microvasculature

European Journal of Pharmacology

Volumn 735, Issue 1, 2014, Pages 105-114

  Macintyre, Jessica ^a   Dong, Alex ^a   Straiker, Alex ^c   Zhu, Jiequan ^a   Howlett, Susan E ^a   Bagher, Amina ^a   Denovan Wright, Eileen ^a   Yu, Dao Yi ^b,d   Kelly, Melanie E M ^a,b  

^a DALHOUSIE UNIVERSITY   (Canada)

^b DALHOUSIE UNIVERSITY   (Canada)

^c INDIANA UNIVERSITY   (United States)

^d UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Cannabinoid; GPR18; Microvasculature; Retina

Indexed keywords

APAMIN; CANNABIDIOL; CANNABINOID; CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; CELL PROTEIN; ENDOTHELIN 1; GLYCINE DERIVATIVE; GPR18 PROTEIN; MESSENGER RNA; N ARACHIDONYL GLYCINE; NITRIC OXIDE SYNTHASE; UNCLASSIFIED DRUG; 4-(3-3,4-P-MENTHADIEN-(1,8)-YL)OLIVETOL; ARACHIDONIC ACID DERIVATIVE; CANNABINOID RECEPTOR; G PROTEIN COUPLED RECEPTOR; GLYCINE; GPR18 PROTEIN, RAT; GPR55 PROTEIN, RAT; LIPID; N-ARACHIDONYLGLYCINE; RESORCINOL DERIVATIVE;

ADULT; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL DIAMETER; CONTROLLED STUDY; DNA SEQUENCE; ENZYME INHIBITION; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN TARGETING; RAT; RETINA BLOOD VESSEL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY ANALYSIS; SIGNAL TRANSDUCTION; VASOCONSTRICTION; VASODILATATION; ANALOGS AND DERIVATIVES; ANIMAL; DRUG EFFECTS; FISCHER 344 RAT; FRONTAL LOBE; GENETICS; METABOLISM; MICROVASCULATURE; PHYSIOLOGY; RETINA;

ANIMALS; ARACHIDONIC ACIDS; CANNABINOIDS; ENDOTHELIN-1; FRONTAL LOBE; GLYCINE; LIPIDS; MALE; MICROVESSELS; RATS, INBRED F344; RECEPTORS, CANNABINOID; RECEPTORS, G-PROTEIN-COUPLED; RESORCINOLS; RETINA; RETINAL VESSELS; RNA, MESSENGER; VASODILATION;

EID: 84899781790     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2014.03.055     Document Type: Article

References (69)

1. J.C. Ashton The atypical cannabinoid O-1602: targets, actions, and the central nervous system Cent. Nerv. Syst. Agents Med. Chem. 12 2012 233 239
2. J.C. Ashton, and M. Glass The cannabinoid CB2 receptor as a target for inflammation-dependent neurodegeneration Curr. Neuropharmacol. 5 2007 73 80
3. M. Baranowska-Kuczko, M.R. MacLean, H. Kozlowska, and B. Malinowska Endothelium-dependent mechanisms of the vasodilatory effect of the endocannabinoid, anandamide, in the rat pulmonary artery Pharmacol. Res. 66 2012 251 259
4. A.I. Bondarenko, K. Drachuk, O. Panasiuk, V. Sagach, A.T. Deak, R. Malli, and W.F. Graier N-arachidonoyl glycine suppresses Na(+)/Ca(2+) exchanger-mediated Ca(2+) entry into endothelial cells and activates BKCa channels independently of GPCRs Br. J. Pharmacol. 169 2013 933 948
5. J. Bouskila, P. Javadi, C. Casanova, M. Ptito, and J.F. Bouchard Rod photoreceptors express GPR55 in the adult vervet monkey retina PLoS One 8 11 2013 e81080
6. H.B. Bradshaw, S.H. Lee, and D. McHugh Orphan endogenous lipids and orphan GPCRs: a good match Prostaglandins Other Lipid Mediat. 89 2009 131 134
7. M.D. Caldwell, S.S. Hu, S. Viswanathan, H. Bradshaw, M.E. Kelly, and A. Straiker A GPR18-based signaling system regulates IOP in murine eye Br. J. Pharmacol. 169 2013 834 843
8. L. Console-Bram, J. Marcu, and M.E. Abood Cannabinoid receptors: nomenclature and pharmacological principles Prog. Neuropsychopharmacol. Biol. Psychiatry 38 2012 4 15
9. 2+ entry by preventing STIM1-Orai1 interaction J. Cell Sci. 126 2013 879 888
10. E.M. Denovan-Wright, and H.A. Robertson Cannabinoid receptor messenger RNA levels decrease in a subset of neurons of the lateral striatum, cortex and hippocampus of transgenic Huntington's disease mice Neuroscience 98 2000 705 713
11. V. Di Marzo, and L. De Petrocellis Endocannabinoids as regulators of transient receptor potential (TRP) channels: a further opportunity to develop new endocannabinoid-based therapeutic drugs Curr. Med. Chem. 17 2010 1430 1449
12. V. Di Marzo The endocannabinoid system: its general strategy of action, tools for its pharmacological manipulation and potential therapeutic exploitation Pharmacol. Res. 60 2009 77 84
13. E.F. Ellis, S.F. Moore, and K.A. Willoughby Anandamide and delta 9-THC dilation of cerebral arterioles is blocked by indomethacin Am. J. Physiol. 269 1995 H1859 H1864
14. K. Green, H. Wynn, and K.A. Bowman A comparison of topical cannabinoids on intraocular pressure Exp. Eye Res. 17 1978 239 246
15. K. Green The ocular effects of cannabinoids Curr. Top. Eye Res. 1 1979 175 215
16. P. Gyombolai, D. Pap, G. Turu, K.J. Catt, G. Bagdy, and L. Hunyady Regulation of endocannabinoid release of G proteins: a paracrine mechanism of G protein-coupled receptor action Mol. Cell. Endocrinol. 353 2012 29 36
17. T.W. Hein, Y. Ren, Z. Yuan, W. Xu, S. Somvanshi, T. Nagaoka, A. Yoshida, and L. Kuo Functional and molecular characterization of the endothelin system in retinal arterioles Invest. Ophthalmol. Vis. Sci. 50 2009 3329 3336
18. C.M. Henstridge Off-target cannabinoid effects mediated by GPR55 Pharmacology 89 2012 179 187
19. C.M. Henstridge, N.A. Balenga, R. Schroder, J.K. Kargl, W. Platzer, L. Martini, S. Arthur, J. Penman, J.L. Whistler, E. Kostenis, M. Waldhoer, and A.J. Irving GPR55 ligands promote receptor coupling to multiple signaling pathways Br. J. Pharmacol. 160 2010 604 614
20. Heynen-Genel, S.; Dahl, R.; Shi, S.; Milan, L.; Hariharan, S.; Bravo, Y.; Sergienko, E.; Hedrick, M.; Dad, S.; Stonich, D.; Su, Y.; Vicchiarelli, M.; Mangravita-Novo, A.; Smith, L.H.; Chung, T.D.Y.; Sharir, H.; Barak, L.S.; Abood, M.E.; 2010. Screening for selective ligands for GPR55 - agonists. In: Proceedings of the Probe Reports from the NIH Molecular Libraries Program. National Center for Biotechnology Information (US), Bethesda (MD). Available from: http://www.ncbi.nlm.nih.gov/books/NBK66152/.
21. W.S. Ho, and M.D. Randall Endothelium-dependent metabolism by endocannabinoid hydrolases and cyclooxygenases limits vasorelaxation to anandamide and 2-arachidonoylglycerol Br. J. Pharmacol. 150 2007 641 651
22. W.S. Ho, and C.R. Hiley Vasodilator actions of abnormal-cannabidiol in rat isolated small mesenteric artery Br. J. Pharmacol. 138 2003 1320 1332
23. P.M. Hoi, C. Visintin, M. Okuyama, S.M. Gardiner, S.S. Kaup, T. Bennett, D. Baker, D.L. Selwood, and C.R. Hiley Vascular pharmcology of a novel cannabinoid-like compound, 3-(5-dimethylcarbamoyl-pent-1-enyl)-N-(2-hydroxy-1- methyl-ethyl)benzamide (VSN16) in rat Br. J. Pharmacol. 152 2007 751 764
24. A.C. Howlett, C.S. Breivogel, S.R. Childers, S.A. Deadwyler, R.E. Hampson, and L.J. Porrino Cannabinoid physiology and pharmacology: 30 years of progress Neuropharmacology S47 Suppl 1 2004 345 S358
25. S.S. Hu, A. Arnold, J.M. Hutchens, J. Radicke, B.F. Cravatt, J. Wager-Miller, K. Mackie, and A. Straiker Architecture of cannabinoid signaling in mouse retina J. Comp. Neurol. 518 2010 3848 3866
26. Z. Járai, J.A. Wagner, K. Varga, K.D. Lake, D.R. Compton, B.R. Martin, A.M. Zimmer, T.I. Bonner, N.E. Buckley, E. Mezey, R.K. Razdan, A. Zimmer, and G. Kunos Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors Proc. Natl. Acad. Sci. 96 1999 14136 14141
27. D.G. Johns, D.J. Behm, D.J. Walker, Z. Ao, E.M. Shapland, D.A. Daniels, M. Riddick, S. Dowell, P.C. Staton, P. Green, U. Shabon, W. Bao, N. Aiyar, T.L. Yue, A.J. Brown, A.D. Morrison, and S.A. Douglas The novel endocannabinoid receptor GPR55 is activated by atypical cannabinoids but does not mediate their vasodilator effects Br. J. Pharmacol. 152 2007 825 831
28. A. Kapur, P. Zhao, H. Sharir, Y. Bai, M.G. Caron, L.S. Barak, and M.E. Abood Atypical responsiveness of the orphan receptor GPR55 to cannabinoid ligands J. Biol. Chem. 284 2009 29817 29827
29. M. Kohno, H. Hasegawa, A. Inoue, M. Muraoka, T. Miyazaki, K. Oka, and M. Yasukawa Identification of N-arachidonylglycine as the endogenous ligand for orphan G-protein-coupled receptor GPR18 Biochem. Biophys. Res. Commun. 347 2006 827 832
30. H. Kozlowska, M. Baranowska, E. Schlicker, M. Kozlowski, J. Laudanski, and B. Malinowska Identification of the vasodilatory endothelial cannabinoid receptor in the human pulmonary artery J. Hypertens. 25 2007 2240 2248
31. V.B. Lu, H.L. Puhl 3rd, and S.R. Ikeda N-Arachidonyl glycine does not activate G protein-coupled receptor 18 signaling via canonical pathways Mol. Pharmacol. 83 2013 267 282
32. J.N. MacIntyre, J.E. Slusar, J. Zhu, A.X. Dong, S.E. Howlett, and M.E. Kelly Age-associated alterations in retinal arteriole reactivity to endothelin-1 differ between the sexes Mech. Ageing Dev. 133 2012 611 619
33. K. Mackie Cannabinoid receptors: where they are and what they do J. Neuroendocrinol. 20 Suppl 1 2008 10 14
34. K. Mackie Signaling via CNS cannabinoid receptors Mol. Cell. Endocrinol. 286 2008 S60 S65
35. K. Mackie, and N. Stella Cannabinoid receptors and endocannabinoids: evidence for new players AAPS J. 8 2006 E298 E306
36. L.A. Matsuda, S.J. Lolait, M.J. Brownstein, A.C. Young, and T.I. Bonner Structure of a cannabinoid receptor and functional expression of the cloned cDNA Nature 346 1990 561 564
37. S. Mazzetti, S. Frigerio, M. Gelati, A. Salmaggi, and L. Vitellaro-Zuccarello Lycopersicon esculentum lectin: an effective and versatile endothelial marker of normal and tumoral blood vessels in the central nervous system Eur. J. Histochem. 48 2004 423 428
38. D. McHugh GPR18 in microglia: implications for the CNS and endocannabinoid system signaling Br. J. Pharmacol. 167 2012 1575 1582
39. D. McHugh, J. Page, E. Dunn, and H.B. Bradshaw Δ(9) - Tetrahydrocannabinol and N-arachidonyl glycine are full agonists at GPR18 receptors and induce migration in human endometrial HEC-1B cells Br. J. Pharmacol. 165 2012 2414 2424
40. D. McHugh, J. Wager-Miller, J. Page, and H.B. Bradshaw siRNA knockdown of GPR18 receptors in BV-2 microglia attenuates N-arachidonoyl glycine-induced cell migration J. Mol. Signal 7 2012 (10-2187-7-10)
41. D. McHugh, S.S. Hu, N. Rimmerman, A. Juknat, Z. Vogel, J.M. Walker, and H.B. Bradshaw N-arachidonoyl glycine, an abundant endogenous lipid, potently drives directed cellular migration through GPR18, the putative abnormal cannabidiol receptor BMC Neurosci. 11 2010 (44-2202-11-44)
42. S. Munro, K.L. Thomas, and M. Abu-Shaar Molecular characterization of a peripheral receptor for cannabinoids Nature 365 1993 61 65
43. L. Offertaler, F.M. Mo, S. Batkai, J. Liu, M. Begg, R.K. Razdan, B.R. Martin, R.D. Bukoski, and G. Kunos Selective ligands and cellular effectors of a G protein-coupled endothelial cannabinoid receptor Mol. Pharmacol. 63 2003 699 705
44. S.E. O'Sullivan, D.A. Kendall, and M.D. Randall Heterogeneity in the mechanisms of vasorelaxation to anandamide in resistance and conduit rat mesenteric arteries Br. J. Pharmacol. 142 2004 435 442
45. P. Pacher, and G. Kunos Modulating the endocannabinoid system in human health and disease - successes and failures FEBS J. 280 2013 1918 1943
46. N. Parmar, and W.S. Ho N-arachidonoyl glycine, an endogenous lipid that acts as a vasorelaxant via nitric oxide and large conductance calcium-activated potassium channels Br. J. Pharmacol. 160 2010 594 603
47. R.G. Pertwee, A.C. Howlett, M.E. Abood, S.P. Alexander, V. Di Marzo, M.R. Elphick, P.J. Greasley, H.S. Hansen, G. Kunos, K. Mackie, R. Mechoulam, and R.A. Ross International union of basic and clinical pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB(1) and CB(2) Pharmacol. Rev. 62 2010 588 631
48. N. Plange, K.O. Arend, M. Kaup, B. Doehmen, H. Adams, S. Hendricks, A. Cordes, J Huth, W.E. Sponsel, and A Remky Dronabinol and retinal hemodynamics in humans Am. J. Ophthalmol. 143 1 2007 173 174
49. G.A. Porter, G.E. Palade, and A.J. Milici Differential binding of the lectins Griffonia simplicifolia I and Lycopersicon esculentum to microvascular endothelium: organ-specific localization and partial glycoprotein characterization Eur. J. Cell Biol. 51 1990 85 95
50. P.F. Pratt, C.J. Hillard, W.S. Edgemond, and W.B. Campbell N-arachidonylethanolamide relaxation of bovine coronary artery is not mediated by CB1 cannabinoid receptor Am. J. Physiol. 274 1998 H375 H381
51. Z. Qiao, A. Kumar, P. Kumar, and Z.H. Song Involvement of a non-CB1/CB2 cannabinoid receptor in the aqueous humor outflow-enhancing effects of abnormal-cannabidiol Exp. Eye Res. 100 2012 59 64
52. M.D. Randall, and D.A. Kendall Involvement of a cannabinoid in endothelium-derived hyperpolarizing factor-mediated coronary vasorelaxation Eur. J. Pharmacol. 335 1997 205 209
53. S. Rom, and Y. Persidsky Cannabinoid receptor 2: potential role in immunomodulation and neuroinflammation J. Neuroimmune. Pharmacol. 8 2013 608 620
54. E. Ryberg, N. Larsson, S. Sjogren, S. Hjorth, N.O. Hermansson, J. Leonova, T. Elebring, K. Nilsson, T. Drmota, and P.J. Greasley The orphan receptor GPR55 is a novel cannabinoid receptor Br. J. Pharmacol. 152 2007 1092 1101
55. Y.Z. Shoshani, A. Harris, M.M. Shoja, D. Rusia, B. Siesky, Y. Arieli, and B. Wirostko Endothelin and its suspected role in the pathogenesis and possible treatment of glaucoma Curr. Eye Res. 37 2012 1 11
56. J.E. Slusar, E.A. Cairns, A.M. Szczesniak, H.B. Bradshaw, A. Di Polo, and M.E. Kelly The fatty acid amide hydrolase inhibitor, URB597, promotes retinal ganglion cell neuroprotection in a rat model of optic nerve axotomy Neuropharmacology 72C 2013 116 125
57. C. Stanley, and S.E. O'Sullivan Vascular targets for cannabinoids: animal and human studies Br. J. Pharmacol. 2013 10.1111/bph.12560 ([Epub ahead of print] PubMed PMID: 24329566)
58. 2+-activated ion channels modulates endothelin 1 signaling in retinal arteriolar smooth muscle Invest. Ophthalmol. Vis. Sci. 53 2012 3059 3066
59. A. Straiker, N. Stella, D. Piomelli, K. Mackie, H.J. Karten, and G. Maguire Cannabinoid CB1 receptors and ligands in vertebrate retina: localization and function of an endogenous signaling system Proc. Natl. Acad. Sci. USA 96 1999 14565 14570
60. A.J. Straiker, G. Maguire, K. Mackie, and J. Lindsey Localization of cannabinoid CB1 receptors in the human anterior eye and retina Invest. Ophthalmol. Vis. Sci. 40 1999 2442 2448
61. I. Svizenska, P. Dubovy, and A. Sulcova Cannabinoid receptors 1 and 2 (CB1 and CB2), their distribution, ligands and functional involvement in nervous system structures - a short review Pharmacol. Biochem. Behav. 90 2008 501 511
62. A.M. Szczesniak, Y. Maor, H. Robertson, O. Hung, and M.E. Kelly Nonpsychotropic cannabinoids, abnormal cannabidiol and canabigerol-dimethyl heptyl, act at novel cannabinoid receptors to reduce intraocular pressure J. Ocul. Pharmacol. Ther. 27 2011 427 435
63. M. Szekeres, G.L. Nadasy, G. Turu, E. Soltesz-Katona, Z.E. Toth, A. Balla, K.J. Catt, and L. Hunyady Angiotensin II induces vascular endocannabinoid release, which attenuates its vasoconstrictor effect via CB1 cannabinoid receptors J. Biol. Chem. 287 2012 31540 31550
64. R. Takenouchi, K. Inoue, Y. Kambe, and A. Miyata N-arachidonoyl glycine induces macrophage apoptosis via GPR18 Biochem. Biophys. Res. Commun. 418 2012 366 371
65. J.A. Wagner, K. Varga, Z. Jarai, and G. Kunos Mesenteric vasodilation mediated by endothelial anandamide receptors Hypertension 33 1999 429 434
66. A.J. Wheal, S.P. Alexander, and M.D. Randall Vasorelaxation to N-oleoylethanolamine in rat isolated arteries: mechanisms of action and modulation via cyclooxygenase activity Br. J. Pharmacol. 160 2010 701 711
67. S. Yazulla Endocannabinoids in the retina: from marijuana to neuroprotection Prog. Retin. Eye Res. 27 2008 501 526
68. H. Yin, A. Chu, W. Li, B. Wang, F. Shelton, F. Otero, D.G. Nguyen, J.S. Caldwell, and Y.A. Chen Lipid G protein-coupled receptor ligand identification using beta-arrestin PathHunter assay J. Biol. Chem. 284 2009 12328 12338
69. A. Zakrzeska, E. Schlicker, M. Baranowska, H. Kozlowska, G. Kwolek, and B. Malinowska A cannabinoid receptor, sensitive to O-1918, is involved in the delayed hypotension induced by anandamide in anaesthetized rats Br. J. Pharmacol. 160 2010 574 584